Our European “Valvosoft® Pivotal Study” is proceeding as planned, and we are extremely pleased to announce that 3 patients with aortic stenosis, the most common heart valve disease in adults, have been  treated with our non-invasive ultrasound therapy (NIUT) device at the Amphia Hospital in Breda, the Netherlands.

Soon, we will start patients inclusions in Germany.
We can’t wait to share the results that bring us one step closer to CE marking and we are pleased to contribute to the excellence and influence of the French ultrasound therapy industry.

Thank you to all those who put their trust in us – shareholders, cardiologists, patients, academic partners and other supports – and allowed us to reach our goals in 2022. The adventure continues, so stay tuned!
 
We wish you all a happy and prosperous year 2023.
 
Amphia Ziekenhuis Hospital
#focusedultrasound #echotherapy #heartvalvadisease #aorticstenosis #cardiology #ultrasound